Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
Venture Capital News Daily
Amp Human Secures Seed Investment

PARK CITY, UT, Amp Human has received a major investment from NEXT VENTURES.
Click here for more funding data on Amp Human
To export Amp Human funding data to PDF and Excel, click here
Amp Human, creators of a new category of products to help athletes of all types push their limits, today announced it has received a major investment from NEXT VENTURES, a venture capital firm designed to maximize growth opportunities in the sports, fitness, nutrition and wellness markets. NEXT VENTURES, founded by Lance Armstrong, a globally known cyclist and endurance athlete, and investment industry veteran Lionel Conacher, is the lead investor in the seed round. A former CEO and experienced board member, NEXT VENTURES' Managing Partner Conacher will assume a seat on Amp's board.

The investment will be used to grow the sales and marketing teams for Amp Human's first product PR Lotion, which is a ground-breaking electrolyte lotion that uses a patent pending skin absorption technology to neutralize acid buildup in muscles during exercise. The company also plans to establish a scientific advisory board and expand its R&D for additional products in its pipeline.

"Our firm is focused on investing in innovative products that solve a universal fitness need and PR Lotion is an excellent example of a breakthrough product that solves a major problem for the mass market athlete as well as for the elite competitive athlete," said Lance Armstrong, NEXT VENTURES' Managing Partner. "We have early access to many new products, but we knew as soon as we got to know the Amp Human team and tested their product that this company would lead the way in producing market-leading products that create better athletic performance while solving associated limiters. This goes to the heart of what we are looking to invest in and partner with."

PR Lotion is the only product able to deliver bicarb (sodium bicarbonate or baking soda) a natural electrolyte to working muscles, neutralizing the acid buildup that occurs during exercise. Independent studies have shown PR Lotion to increase the number of exercise intervals to exhaustion by 25% and to decrease Delayed Onset Muscle Soreness (DOMS) by 53%.

Bicarb's ability to aid muscle endurance is well documented, but ingesting it has unpleasant results. PR Lotion is the first to use a patent pending process that allows the body to absorb bicarb through the skin, now making the long-standing practice of bicarb loading practical for all athletes. Amp Human's founders, Jeff Byers and Erica Good, met at the biotech firm that developed this delivery technology, licensing the technology and creating the brand a year ago.

"My co-founder, Erica Good and I are honored that a firm like Next Ventures has joined forces with Amp Human," said CEO Jeff Byers. "As a company, our goal is nothing less than to establish a new horizon for human athletic achievement. PR Lotion is the first step. We will continue to identify the limiters of human performance and develop products that address those limiters."

About Amp Human
Based in Park City, UT, Amp Human's mission is to fundamentally raise human capacity by creating a trusted new category of products to help athletes of all types push their limits. Their flagship product, PR Lotion, is relied on by the world's best athletes to give their bodies more bicarb to neutralize acid in muscles which helps them push harder and recover faster. For more information visit Amp Human and follow on @AMPHUMAN.

NEXT VENTURES is an Austin-based venture capital firm designed to maximize growth opportunities in the exploding sports, fitness and wellness markets. With established expertise and deep connections in these markets as well as proven financial track records, the NEXT VENTURES team is well positioned to create significant value for their portfolio companies. For more information visit
(c)2011-2018 by Massinvestor, Inc. For contact info, please check out our about page.
  >> Click here for in-depth research on 4,000 VC firms
Venture Capital News Daily
Massinvestor/VC News Daily

© 2018 Massinvestor, Inc.